Clinical Trial Update: Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating valproic acid and simvastatin with gemcitabine and nab-paclitaxel regimens in untreated metastatic pancreatic adenocarcinoma; status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• SIMVASTATIN (SIMVASTATIN)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Adenocarcinoma of the Pancreas | Phase 2 | Status: RECRUITING